INSIGHTS ON CLINICAL TRIAL DESIGN
-
Next-Generation ADC Trials – Turning Complexity Into Execution
As ADC science advances, operational strategy becomes critical. Learn how smarter protocol design, real-time monitoring and collaborative execution can accelerate next-generation ADC trials.
-
The Triple Effect Of Community-Based Clinical Trials
Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.
-
Factors Affecting Systemic Drug Exposure
The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.
-
Real-World Data Has Real Impact On Clinical Research
The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
-
GA Screening: Early Detection For Future Trial Recruitment4/9/2026
Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.
-
From Data To Decisions: Accelerating Clinical Development In The AI Era7/10/2026
AI and connected data are reducing delays and complexity in clinical development — when paired with strong data foundations, smarter workflows, and human‑centered change.
-
Balancing Patient Centricity With Complexity In Cancer Trials10/28/2025
By bringing clinical research closer to where patients live and receive care, sponsors and CROs can expand reach, reduce travel burdens, and engage populations historically underrepresented in cancer studies.
-
How Pharmacometrics Informs Dose Selection And Biomarker Decisions6/10/2026
Quantitative modeling guides early dose and biomarker insights, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
-
Early Detection vs. Overdiagnosis: The ctDNA Screening Paradox6/4/2026
Discover how ctDNA could transform early cancer detection and why the BRCA model offers important lessons for balancing innovation, risk, and meaningful patient outcomes.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.
-
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.